A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2011
05/19/2011	US20110118239 Preparation and enantiomeric separation of 7-(3-pyridinyl)-1,7-diazaspiro[4.4]nonane and novel salt forms of the racemate and enantiomers
05/19/2011	US20110118238 2-anilinopurin-8-ones as inhibitors of ttk/mps1 for the treatment of proliferative disorders
05/19/2011	US20110118237 Isoxazoline linked pyrrolo[2,1-c][1,4]benzodiazepine hybrids as potential anticancer agents and the process for preparation thereof
05/19/2011	US20110118236 Heterocyclic compound
05/19/2011	US20110118235 Substituted benzoazepines as toll-like receptor modulators
05/19/2011	US20110118234 Urea Compounds as Gamma Secretase Modulators
05/19/2011	US20110118233 Certain Substituted Amides, Method of Making, and Method of Use Thereof
05/19/2011	US20110118232 Pyrimidine compounds and use thereof
05/19/2011	US20110118231 Modulators of 5-ht receptors and methods of use thereof
05/19/2011	US20110118230 Diazacarbazoles and methods of use
05/19/2011	US20110118229 2-arylmethylazetidine-carbapenem-3-carboxylic acid ester derivative or its salt, process for the preparation thereof and pharmaceutical composition comprising the same
05/19/2011	US20110118228 Enzymatic production or chemical synthesis and uses for 5,7-dienes and UVB conversion products thereof
05/19/2011	US20110118227 Methods for the Treatment of Fibromyalgia and Chronic Fatigue Syndrome
05/19/2011	US20110118226 Transdermal pharmaceutical compositions comprising danazol
05/19/2011	US20110118225 Ligands of Estrogen Receptors alpha and beta, Method of Their Preparation, and Pharmaceuticals Comprising Them
05/19/2011	US20110118224 Use of steroid sulfatase inhibitors for the treatment of preterm labor
05/19/2011	US20110118223 Novel quinuclidine derivatives and medicinal compositions containing the same
05/19/2011	US20110118222 Pseudolipid complex mixture and a skin external application composition containing same
05/19/2011	US20110118221 1,4-diaryl-pyrimidopyridazine-2,5-diones and their use
05/19/2011	US20110118220 Composition of bifonazole and its use
05/19/2011	US20110118219 Novel prodrugs of c-17-heteroaryl steroidal cyp17 inhibitors/antiandrogens: synthesis, in vitro biological activities, pharmacokinetics and antitumor activity
05/19/2011	US20110118218 Treating hypertension with 25-hydroxyvitamin d3
05/19/2011	US20110118217 Agonists for Antimicrobial Peptide Systems
05/19/2011	US20110118216 Tigecycline Compositions and Methods of Preparation
05/19/2011	US20110118215 7,8 And 9-Substituted Tetracycline Compounds
05/19/2011	US20110118214 Ligands specific for cannabinoid receptor subtype 2
05/19/2011	US20110118213 Compounds and methods for delivery of prostacyclin analogs
05/19/2011	US20110118212 Pestcidal active mixtures comprising isoxazoline compounds I
05/19/2011	US20110118211 Novel glucokinase activators and methods of using same
05/19/2011	US20110118210 Aminopropanol derivatives
05/19/2011	US20110118209 Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents
05/19/2011	US20110118208 Thiazolyl-Dihydro-Indazoles
05/19/2011	US20110118207 Modified hydroxypolymer conjugates with bone seeking and tumor killing moieties
05/19/2011	US20110118205 Anti-tumor agent comprising cytidine derivative and carboplatin
05/19/2011	US20110118204 Nutritional composition with free amino acids and structured lipids
05/19/2011	US20110118203 Novel Crystalline Forms Of An Antiviral Benzimidazole Compound
05/19/2011	US20110118202 Molecules which Bind to the Dimerization Initiation Site (DIS) of HIV RNA, Their Synthesis and Their Applications as Drugs
05/19/2011	US20110118201 Glutathione production enhancer, prophylactic/therapeutic agent for diseases caused by glutathione deficiency, and food, beverage and feed
05/19/2011	US20110118200 A pegylated and fatty acid grafted chitosan oligosaccharide, synthesis method and application for drug delivery system
05/19/2011	US20110118199 Use of cns penetrating anticancer compounds for the treatment of protozoal diseases
05/19/2011	US20110118198 Polysulfated glycosides and salts thereof
05/19/2011	US20110118197 Prevention of hepatic ischemic reperfusion injury by administration of sulfatides
05/19/2011	US20110118196 Anti-phthiraptera treatment compositions
05/19/2011	US20110118192 Methods and compositions for treating t-cell leukemia
05/19/2011	US20110118189 Novel formulations for treatment of migraine
05/19/2011	US20110118187 Reversible platelet inhibition
05/19/2011	US20110118180 Method of treatment of diabetes type 2 comprising add-on therapy to metformin
05/19/2011	US20110118174 Treatment solution and method for preventing posterior capsular opacification by selectively inducing detachment and/or death of lens epithelial cells
05/19/2011	US20110118171 Process for producing fatty acid and active ingredient extracts, and fatty acids and active ingredients themselves
05/19/2011	US20110118122 Insecticidal pyridine compounds
05/19/2011	US20110118116 Azolin-2-ylamino Compounds for Combating Animal Pests
05/19/2011	US20110117646 Antisense modulation of c-reactive protein expression
05/19/2011	US20110117228 Compositions and methods for enhancing and treating female sexual response
05/19/2011	US20110117224 Composition Comprising Bamboo Extract and the Compounds Isolated Therefrom Showing Treating and Preventing Activity for Inflammatory and Blood Circulation Disease
05/19/2011	US20110117223 Antiseptics
05/19/2011	US20110117219 Hair treatment product and hair after-treatment product containing ether guanidines as active substances, for protecting from damage caused by chemical treatment and for repairing already damaged hair
05/19/2011	US20110117216 Anti-tumoural effects of cannabinoid combinations
05/19/2011	US20110117215 Microsatellite Markers of Schizophrenia
05/19/2011	US20110117214 Cyclohexyl urea modulators of d2 receptors and/or d3 receptors
05/19/2011	US20110117213 Treatment of acute exacerbation of asthma and reduction of likelihood of hospitalization of patients suffering therefrom
05/19/2011	US20110117212 Therapeutic combination comprising an aurora kinase inhibitor and an antineoplastic agent
05/19/2011	US20110117211 Method of Treating or Preventing Tissue Deterioration, Injury or Damage Due to Disease of Mucosa
05/19/2011	US20110117210 Therapeutic treatment of human cancers using simple salts of zinc
05/19/2011	US20110117205 Oral pharmaceutical formulation in the form of aqueous suspension for modified release of active principle(s)
05/19/2011	US20110117203 Pharmaceutical composition containing water soluble drug
05/19/2011	US20110117202 Up and down conversion systems for production of emitted light from various energy sources including radio frequency, microwave energy and magnetic induction sources for upconversion
05/19/2011	US20110117200 Rasagiline mesylate particles and process for the preparation thereof
05/19/2011	US20110117198 Compositions of semi-interpenetrating polymer network
05/19/2011	US20110117197 Sustained-release drug carrier composition
05/19/2011	US20110117196 Analgetic dosage forms that are resistant to parenteral and inhalation dosing and have reduced side effects
05/19/2011	US20110117194 Pharmaceutical formulation containing angiotensin-ii receptor blocker
05/19/2011	US20110117193 Antiretroviral drug formulations for treatment of children exposed to hiv/aids
05/19/2011	US20110117192 Carbidopa/lipodopa gastroretentive drug delivery
05/19/2011	US20110117189 Ophthalmic compositions for treating pathologies of the posterior segment of the eye
05/19/2011	US20110117188 Group of Nucleic Acid Fragments for Prevention of HIV Infection or AIDS and the Usage Thereof
05/19/2011	US20110117187 Topical compositions and methods for epithelial-related conditions
05/19/2011	US20110117186 Intravenous infusion of curcumin and a calcium channel blocker
05/19/2011	US20110117185 Methods for treating or preventing heart damage with integrin-linked kinase (ilk) compositions
05/19/2011	US20110117184 Compositions for mucosal delivery of agents
05/19/2011	US20110117182 Combination of dapsone with other anti-acne agents
05/19/2011	US20110117181 Treating hepatitis c virus infection with over-expression of microrna-196
05/19/2011	US20110117180 Vegetarian microcapsules
05/19/2011	US20110117175 Sweet analgesic for use in medical procedures or treatments
05/19/2011	US20110117173 Powdered chewing gum compositions, the use thereof and a method of preparing such compositions
05/19/2011	US20110117172 Cross-linked polymer matrix, in particular for administering active substances
05/19/2011	US20110117168 Methods and compositions for soft tissue repair
05/19/2011	US20110117167 Methods and compositions for soft tissue repair
05/19/2011	US20110117165 Implantable bone graft materials
05/19/2011	US20110117164 Use of Additive Sites to Control Nitric Oxide Release from Nitric Oxide Donors Contained within Polymers
05/19/2011	US20110117161 Biologically absorbable coatings for implantable devices and methods for fabricating the same
05/19/2011	US20110117159 Inhibition of jak2 as a treatment of pulmonary arterial hypertension
05/19/2011	US20110117154 Use of rifalazil to treat colonic disorders
05/19/2011	US20110117151 Device,system, and method for targeted delivery of anti-inflammatory medicaments to a mammalian subject
05/19/2011	US20110117150 Device, system, and method for targeted delivery of anti-inflammatory medicaments to a mammalian subject
05/19/2011	US20110117148 Whitened exine shells
05/19/2011	US20110117147 Cooling sensation agent composition and sensory stimulation agent composition
05/19/2011	US20110117141 Methods and compositions comprising novel cationic lipids
05/19/2011	US20110117140 Zinc Salt Compositions for the Prevention of Dermal and Mucosal Irritation
05/19/2011	US20110117125 Compositions and methods for the delivery of nucleic acids
05/19/2011	US20110117118 Molecules, compositions, methods and kits for applications associated with flaviviruses

1 ... 1731 1732 1733 1734 1735 1736 1737 1738 1739 1740 1741 1742 1743 1744 1745 1746 1747 1748 1749 1750 1751 ... 7860